Loading...
•
Dec 31, 2022
Astrana Health Q4 2022 Earnings Report
Announced consolidated financial results, showing revenue increase and a net loss.
Key Takeaways
Apollo Medical Holdings reported a 51% increase in revenue for Q4 2022, reaching $294.2 million. However, the company experienced a net loss attributable to ApolloMed of $2.6 million, compared to a net income of $13.8 million in the prior-year quarter. Adjusted EBITDA increased by 54% to $23.7 million.
Total revenue increased by 51% to $294.2 million compared to the prior-year quarter.
Net loss attributable to ApolloMed was $2.6 million, compared to net income of $13.8 million in the prior-year quarter.
Adjusted EBITDA increased by 54% to $23.7 million compared to the prior-year quarter.
Capitation revenue increased by 63% to $252.9 million compared to the prior-year quarter.
Revenue by Segment
Forward Guidance
ApolloMed provided guidance for the year ending December 31, 2023, with total revenue expected to be between $1.3 billion and $1.5 billion.
Positive Outlook
- Total revenue is expected to be between $1.3 billion and $1.5 billion.
- Net income is projected to be between $49.5 million and $71.5 million.
- EBITDA is anticipated to range from $89.5 million to $129.5 million.
- Adjusted EBITDA is forecasted to be between $120.0 million and $160.0 million.
- EPS – diluted is expected to be between $0.95 and $1.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...